We responded, with the British Society of Antimicrobial Chemotherapy, to an inquiry on antimicrobial resistance by the Department of Health and Social Care. The British…
It’s OK. I get it. My enthusiasm is a little over-the-top. But ‘c’mon!’ (to borrow a phrase from fellow enthusiastic-type, Australian tennis player Lleyton Hewitt), G protein-coupled receptors…
A review of nine observational studies found evidence supporting an increased risk of heart attacks in patients taking antipsychotic drugs. The review expands previous knowledge by demonstrating an…
Antonios Diab is a postdoctoral fellow with the Canadian Society of Pharmacology and Therapeutics and at the College of Pharmacy, Dalhousie University. Antonios has trained in neuroscience and…
In November 2020, the All-Party Parliamentary Group (APPG) on Diversity and Inclusion in Science, Technology, Engineering and Maths (STEM) launched its new inquiry into Equity in the…
Applications for our 2025 awards are now open! Our awards provide our members with career development opportunities and funding, as well as recognition for important pharmacology-related…
A new funding requirement from the Medical Research Council (MRC) came into play from September 2022, necessitating that both sexes are incorporated into the experimental design of grant applications…
Bacteriophages, or simply phages, are viruses that infect and replicate within bacteria, and they hold considerable potential for combatting antibiotic-resistance and other threats to human health.…
Aroon is director at UCL's Institute of Cardiovascular Science and a consultant in clinical pharmacology and General (Internal) Medicine at University College London and UCL Hospitals NHS…
